Opportunity
SAM #HT940827Q0003
Wilford Hall intends to sole-source bioMérieux microbiology testing systems, supplies, software, and maintenance
Buyer
Defense Health Agency
Posted
October 08, 2026
Respond By
October 12, 2026
Identifier
HT940827Q0003
NAICS
334516, 811210, 325413
The Defense Health Agency’s Wilford Hall Ambulatory Surgical Center plans to sole-source microbiology testing equipment, supplies, software, and maintenance from bioMérieux, Inc. - Agency and location: Defense Health Agency, Wilford Hall Ambulatory Surgical Center, Lackland MDTS/Laboratory Flight; Wilford Hall Medical Treatment Facility. - Procurement approach: The notice announces an intent to award a sole-source contract to bioMérieux, Inc. Interested sources are invited to provide evidence that competition would benefit the Government without prohibitive cost or schedule impacts. - Equipment and software: VITEK 2 60, AST, VC-VITEK, and BACT/ALERT VIRTUO systems; VITEK 2 and BacT/ALERT 3D systems with MAESTRIA data management and Myla Software 3.1 are also identified. - Supplies: VTK2 identification cards (GP, GN, YST, NH, and ANC), AST-N809, GP67, YS09, VTK2 PIP/DIL, and necessary reagents. Quantities are not specified. - Services: Comprehensive maintenance for the microbiology testing equipment. - Stated capabilities: Up to 240 tests per hour, a first result within 100 minutes, and subsequent results every 15 seconds. The notice also gives instrument dimensions of 215 × 183 × 105 cm and refers to allergen-specific IgE testing capabilities. - Period and amount: November 1, 2026 through October 31, 2027 (one year); stated contract amount is $135,373.31. No option years are specified.
Description
NOTICE OF INTENT TO SOLE SOURCE
The Wilford Hall Ambulatory Surgical Center, Lackland MDTS/Laboratory Flight’s intends to award a sole source contract with bioMérieux, Inc/, to procure a fully automated microbiology instrument that performs rapid microbial identification (ID) and antibiotic susceptibility testing via utilization systems VITEK 2 60, AST, VC-VITEK, and VC-BACT/ALERT VIRTUO systems with MAESTRIA data management. which includes all necessary reagents and comprehensive maintenance services for the Medical Treatment Facility (MTF) Wilford Hall. The Period of Performance is for one (1) year beginning 1 November 2026 through 31 October 2027 in the amount of $135.373.31.
The contractor shall deliver the following crucial elements: Vitek2 and BacT/ALERT 3D with Myla Software, 3.1. System Capabilities - Fully automated immunoassay platform utilizing a solid-phase methodology for allergen-specific IgE detection. Capability to perform simultaneous testing of multiple allergens and allergen components from a single patient sample, VTK2 20CARDS GP, GN, YST, NH, ANC, AST-N809, GP67, YS09, VTK2 PIP/DIL. Quantitative measurement of allergen-specific IgE antibodies. Minimal interference from othermunoglobulins (e.g., IgG). • Dimensions: (H/W/D): 215 x 183 x 105 cm, 3.2. Performance Requirements. High-throughput capability supporting large-scale laboratory operations. Ability to produce 240 tests per hour with first result available in 100 minutes followed by one every 15 seconds.
Interested sources with the demonstrated capability to meet all of the technical requirements outlined in this notice are invited to submit, in writing. Responses must include clear and convincing evidence that competition would be beneficial to the Government and would not be cost or schedule prohibitive. Respondents are responsible for appropriately marking any proprietary information. Responses will not be returned.
This synopsis/notice of intent to sole source is issued in accordance with Federal Acquisition Regulation (FAR) Revolutionary FAR Overhaul (RFO) 5.101 and 12.102 and will be posted for 5 days.
Response Due Date: October 12, 2026 by 12:00 PM (CST)
Submit to: Contracting Officer: Joe D. Wells at joe.d.wells3.civ@health.mil.